Global scientific leaders join four-day event for networking, educational presentations and golf
MELBOURNE, FLA. (PRWEB) OCTOBER 14, 2019
Erchonia, the global leader in the manufacturing and development of low-level laser therapy technology, today announces its upcoming Business Meeting in Orlando & 18th Annual Golf Tournament. The invite-only, four-day event starts Thursday, October 24 at the Ritz Carlton in Orlando, near Erchonia’s headquarters in Melbourne.
The first day will kick off with training and roundtable discussions scheduled with Erchonia’s management, researchers, international partners, college representatives and suppliers from around the world, and concludes with a cocktail party at 7:00 p.m. The second day will be filled with golfing activities at the Ritz Carlton, which has one of the most beautiful, championship-level golf courses in the world. Erchonia’s putting contest will be held from 8:15 a.m. to 9:00 a.m. and the golf tournament will begin at 9:30 a.m. This year’s theme is “College Football Teams,” and golfers are encouraged to wear their college colors proudly.
“Erchonia has established many important relationships over the last two decades,” says Steven Shanks, president of Erchonia Corporation. “With this event, we’re giving our industry leaders, doctors, partners, laser supporters and suppliers the opportunities for these business relationships to grow as we review goals and objectives for 2020 and beyond.”
On Saturday and Sunday, Dr. Dan Murphy, DC, DABCO will teach a special, two-day seminar, and attendees will be able to choose from a variety of breakout sessions. Other diverse health professionals will present on a wide range of topics including the science behind low level lasers, sports medicine, how the Erchonia laser and nutrition work together, strategic marketing for physicians, and much more.
For more information, please visit https://www.erchonia.com/product/erchonias-18th-annual-golf-tournament-orlando-fl/.
About Erchonia Corporation
Based in Melbourne, Florida, family-owned Erchonia is the global leader in the manufacturing and development of low-level laser therapy technology (“3LT®”). From humble beginnings in a garage in 1996, Erchonia today develops and sells the most advanced, non-invasive 3LT medical equipment on the market in over 50 countries. With 17 clearances from the FDA with different indications, Erchonia remains passionately committed to effective, research-based 3LT solutions for a wide variety of conditions — from managing chronic pain to promoting fat loss. For more information, please visit http://www.erchonia.com.
“With this event, we’re giving our industry leaders, doctors, partners, laser supporters and suppliers the opportunities for these business relationships to grow as we review goals and objectives for 2020 and beyond,” says Steven Shanks, president of Erchonia Corporation.